Business Wire

Lineage Cell Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update

CARLSBAD, Calif.--(BUSINESS WIRE)--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel allogeneic, or “off the shelf”, cell ...
Seeking Alpha

IN8bio Presents Positive Data Update from Induced Pluripotent Stem Cell (iPSC) Platform at the Society for Immunotherapy of Cancer (SITC) 38th Annual Meeting

This data represents a step forward in developing next-generation ‘off-the-shelf’ iPSC derived gamma-delta T cells. Our proprietary expansion methods are serum and feeder-free and have the potential ...
Nasdaq

BrainStorm Cell Therapeutics to Host Investor Call and Provide a Corporate Update

Those that wish to listen to the replay of the conference call can do so by dialing the numbers below. The replay will be available until Monday, January 13, 2025. Notice Regarding Forward-Looking ...
Nasdaq

BrainStorm Cell Therapeutics Announces Second Quarter 2025 Financial Results and Provides Corporate Update

View original content to download multimedia:https://www.prnewswire.com/news-releases/brainstorm-cell-therapeutics-announces-second-quarter-2025-financial-results-and ...